These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36124741)

  • 1. Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing.
    Gemikonakli G; Mach J; Zhang F; Bullock M; Tran T; El-Omar E; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2023 Feb; 78(2):213-222. PubMed ID: 36124741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice.
    Mach J; Gemikonakli G; Logan C; Vander Wyk B; Allore H; Ekambareshwar S; Kane AE; Howlett SE; de Cabo R; Le Couteur DG; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1010-1018. PubMed ID: 32147704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial.
    Jamieson H; Nishtala PS; Bergler HU; Weaver SK; Pickering JW; Ailabouni NJ; Abey-Nesbit R; Gullery C; Deely J; Gee SB; Hilmer SN; Mangin D
    J Gerontol A Biol Sci Med Sci; 2023 Aug; 78(9):1692-1700. PubMed ID: 36692224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records.
    Masnoon N; Lo S; Hilmer S
    Br J Clin Pharmacol; 2023 Feb; 89(2):687-698. PubMed ID: 36038522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post Hoc Analyses of a Randomized Controlled Trial for the Effect of Pharmacist Deprescribing Intervention on the Anticholinergic Burden in Frail Community-Dwelling Older Adults.
    Nishtala PS; Pickering JW; Bergler U; Mangin D; Hilmer SN; Jamieson H
    J Am Med Dir Assoc; 2023 Aug; 24(8):1253-1260. PubMed ID: 37339754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    BMJ Open; 2017 Apr; 7(4):e013800. PubMed ID: 28416498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying the AFRAID and FRIGHT Clocks to Novel Preclinical Mouse Models of Polypharmacy.
    Mach J; Kane AE; Howlett SE; Sinclair DA; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2022 Jul; 77(7):1304-1312. PubMed ID: 35313348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical frailty assessments: Phenotype and frailty index identify frailty in different mice and are variably affected by chronic medications.
    Mach J; Allore H; Gnjidic D; Gemikonakli G; Kane AE; Howlett SE; de Cabo R; Le Couteur D; Hilmer SN
    Exp Gerontol; 2022 May; 161():111700. PubMed ID: 35032570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study.
    Reallon E; Chavent B; Gervais F; Dauphinot V; Vernaudon J; Krolak-Salmon P; Mouchoux C; Novais T
    Int J Clin Pharm; 2020 Apr; 42(2):508-514. PubMed ID: 32140916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of deprescribing for older people with frailty and polypharmacy: part one.
    Lyne S
    Nurs Older People; 2023 Oct; 35(5):35-41. PubMed ID: 37670533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions Between the Aging Gut Microbiome and Common Geriatric Giants: Polypharmacy, Frailty, and Dementia.
    Gemikonakli G; Mach J; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1019-1028. PubMed ID: 32064521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom.
    Silcock J; Marques I; Olaniyan J; Raynor DK; Baxter H; Gray N; Zaidi STR; Peat G; Fylan B; Breen L; Benn J; Alldred DP
    Health Expect; 2023 Feb; 26(1):399-408. PubMed ID: 36420768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.
    Sheppard JP; Benetos A; Bogaerts J; Gnjidic D; McManus RJ
    Curr Hypertens Rep; 2024 May; 26(5):225-236. PubMed ID: 38305846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing electronic case reviews for older veterans at risk for falls: Effects on drug burden and falls.
    Pavon JM; Davidson S; Sloane R; Pepin M; Bryan W; Bailey J; Igwe I; Colon-Emeric C
    J Am Geriatr Soc; 2024 Feb; 72(2):433-443. PubMed ID: 37941488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study.
    Fujita K; Hooper P; Masnoon N; Lo S; Gnjidic D; Etherton-Beer C; Reeve E; Magin P; Bell JS; Rockwood K; O'Donnell LK; Sawan M; Baysari M; Hilmer SN
    Drugs Aging; 2023 Jul; 40(7):633-642. PubMed ID: 37160561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.